Results 241 to 250 of about 17,201,482 (284)

Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases. [PDF]

open access: yesBiomedicines
Antosz K   +5 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis. [PDF]

open access: yesERJ Open Res
Kyriakopoulos C   +8 more
europepmc   +1 more source

Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan. [PDF]

open access: yesDrugs
Lombardi C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy